Raymond James Financial Services Advisors, Inc. Nevro Corp Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$101.99 - $166.36 $132,790 - $216,600	-1,302 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$141.6 - $179.06 $184,363 - $233,136	1,302 New	1,302 $216,000
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $162,825 - $223,352	-1,226 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $169,396 - $226,000	1,226 New	1,226 $212,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$19.1 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$16.2 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$15.6 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$10.6 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$9.1 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $154M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account